What Is Camzyos Used for? A Doctor-Reviewed Answer

Camzyos is the brand name for mavacamten. It is used for adults with symptomatic obstructive hypertrophic cardiomyopathy.
Key Takeaways
- Camzyos is the brand name for mavacamten.
- It is used for adults with symptomatic obstructive hypertrophic cardiomyopathy.
- Its goal is to improve symptoms and functional capacity by reducing excessive heart muscle contraction.
- This medicine requires careful follow-up, including heart imaging such as echocardiography.
- New or worsening chest pain, fainting, severe breathlessness, or palpitations need prompt medical review.
Camzyos is used to treat adults with symptomatic obstructive <a href="https://acibademinternational.com/diseases/hypertrophic-cardiomyopathy/”>hypertrophic cardiomyopathy, a heart muscle condition that can block blood flow and cause symptoms such as shortness of breath, chest discomfort, dizziness, or reduced exercise tolerance. It is not a general heart medicine, and doctors prescribe it only after confirming the diagnosis and assessing heart function carefully.
Overview: What Camzyos Is Used For
For many people, occasional breathlessness or tiredness can have harmless explanations such as deconditioning, stress, or a minor illness. However, when these symptoms are persistent, happen with activity, or are linked to chest discomfort, dizziness, or fainting, a doctor may look for a heart-related cause. One important example is obstructive hypertrophic cardiomyopathy, the main condition Camzyos is used to treat.
Camzyos, also known by its generic name mavacamten, is a prescription medicine used in adults with symptomatic obstructive hypertrophic cardiomyopathy. In this condition, the heart muscle becomes abnormally thick, and the thickened muscle can narrow the pathway through which blood leaves the heart. This may make the heart work harder and lead to symptoms such as shortness of breath, chest pain, lightheadedness, palpitations, and reduced ability to exercise.
Camzyos is not a general treatment for all heart failure, all thickened heart muscle, or every type of hypertrophic cardiomyopathy. Its use is specific, and doctors prescribe it only after confirming the diagnosis, evaluating the degree of obstruction, and checking how well the heart is pumping. Because the medicine changes how strongly the heart muscle contracts, ongoing monitoring is an important part of safe treatment.
How Camzyos Works in Obstructive Hypertrophic Cardiomyopathy

Obstructive hypertrophic cardiomyopathy happens when the heart muscle, especially the wall between the lower chambers, becomes too thick. In some people, this thickening partly blocks blood flow out of the heart. The blockage can become more noticeable during exertion, when the heart is beating faster and harder.
Camzyos works differently from many standard heart medicines. It acts on cardiac myosin, a protein involved in heart muscle contraction. By reducing excessive contractility, it can help lessen the obstruction in the outflow tract and improve how efficiently the heart fills and pumps.
This effect may help relieve symptoms and improve day-to-day function in suitable patients. Even so, the medicine needs careful medical supervision because too much reduction in pumping strength can be harmful. That is why doctors use regular echocardiograms and clinical review to decide whether treatment is appropriate and whether it should be adjusted or paused.
Who May Be Prescribed Camzyos

Doctors usually consider Camzyos for adults who have symptomatic obstructive hypertrophic cardiomyopathy confirmed by clinical assessment and heart imaging. Symptoms often include shortness of breath with activity, chest pressure, dizziness, fatigue, or near-fainting. In many cases, the person has already had an evaluation by a cardiologist, often one with expertise in inherited or structural heart disease.
Not everyone with hypertrophic cardiomyopathy is a candidate for this medicine. Some people have non-obstructive disease, which means the heart muscle is thickened but does not significantly block blood flow. Others may have symptoms caused by another condition such as coronary artery disease, arrhythmia, or valve disease, and those causes need separate evaluation.
A doctor also reviews other medicines, medical history, and baseline heart function before prescribing Camzyos. This is important because some drug interactions can affect how Camzyos works, and some patients may need a different treatment strategy. People being assessed for hypertrophic cardiomyopathy may also be advised to have family history review or genetic counseling when appropriate.
Symptoms That Prompt Medical Review
Many symptoms associated with obstructive hypertrophic cardiomyopathy can overlap with less serious problems, especially in early stages. Mild shortness of breath with intense activity or occasional awareness of the heartbeat may not always signal a dangerous condition. Still, symptoms that are new, recurring, or worsening deserve medical attention, particularly if they affect normal activities.
Doctors pay particular attention to symptoms that suggest the heart may be under strain or that blood flow out of the heart is being obstructed. These may include:
- Shortness of breath during routine activity or exercise
- Chest discomfort, pressure, or pain
- Dizziness or lightheadedness
- Fainting or near-fainting
- Palpitations or an irregular heartbeat
- Unusual fatigue or poor exercise tolerance
These symptoms do not automatically mean a person needs Camzyos, but they are reasons for a proper assessment. A doctor will look at the pattern of symptoms, when they occur, what brings them on, and whether there is any family history of heart disease or sudden cardiac events.
How Doctors Diagnose the Condition Before Using Camzyos
Before prescribing Camzyos, doctors first confirm that a person truly has symptomatic obstructive hypertrophic cardiomyopathy. The evaluation usually begins with a medical history and physical examination, including questions about breathlessness, fainting, chest pain, palpitations, exercise limits, and any relatives with known heart conditions.
Tests commonly include an electrocardiogram and, most importantly, an echocardiogram. Echocardiography helps measure the thickness of the heart muscle, shows whether there is obstruction to blood leaving the heart, and checks the ejection fraction, which reflects pumping strength. In some cases, exercise testing, Holter monitoring, or cardiac MRI may also be helpful to clarify the diagnosis and guide treatment planning.
This step is especially important because symptoms such as chest pain or shortness of breath can have several causes. Some patients may need evaluation for cardiology care more broadly, while others may need rhythm monitoring, medication review, or assessment for procedures. A careful diagnosis helps ensure that Camzyos is used in the right setting and that safer or more suitable options are not missed.
Treatment Options Alongside or Instead of Camzyos
Camzyos is one treatment option within a broader care plan for obstructive hypertrophic cardiomyopathy. Depending on symptoms, age, anatomy, heart rhythm, and overall health, doctors may also use other medicines such as beta blockers or certain calcium channel blockers. The aim is to reduce symptoms, improve exercise capacity, and lower the burden of obstruction where possible.
Some people continue to have significant symptoms despite medication. In selected cases, doctors may consider septal reduction therapies, which are procedures designed to lessen the thickened area that blocks blood flow. These options are typically discussed in experienced centers after detailed imaging and multidisciplinary review.
If rhythm problems are part of the picture, management may also include arrhythmia treatment or monitoring for atrial fibrillation and other conduction issues. For patients whose symptoms are severe or whose anatomy is suitable, specialists may discuss advanced approaches within a heart care program. At the end of the assessment, the best treatment is the one that matches the person’s exact diagnosis and current risk profile.
Safety, Monitoring, and Day-to-Day Self-Care
Because Camzyos affects the strength of heart muscle contraction, regular monitoring is a central part of treatment. Doctors usually schedule follow-up visits and repeat echocardiograms to make sure the medicine is helping without reducing the heart’s pumping function too much. Patients should take it only as prescribed and should not change or stop it without medical advice.
It is also important to tell the care team about all other medicines, supplements, and over-the-counter products. Some can interact with Camzyos and change its levels in the body. Patients should also inform clinicians about pregnancy plans, new symptoms, infections, or hospital admissions, since these may affect treatment decisions.
Self-care still matters even when a targeted medicine is prescribed. Helpful measures may include pacing physical activity, staying well hydrated if advised, avoiding sudden overexertion, and following recommendations about exercise, alcohol, and stimulant use. Regular follow-up with a cardiologist remains important because hypertrophic cardiomyopathy can change over time, and treatment often needs periodic review.
When to Seek Medical Care
Medical review is a good idea if a person develops persistent breathlessness, chest discomfort with activity, unexplained dizziness, exercise intolerance, or a racing or irregular heartbeat. These symptoms are often manageable, and many causes are not emergencies, but they should be assessed rather than ignored. Prompt evaluation is especially important if symptoms are becoming more frequent or are limiting daily life.
Urgent care is needed for fainting, severe chest pain, marked shortness of breath, or palpitations with weakness or near-collapse. These symptoms do not always mean a dangerous event, but they require prompt medical attention to rule out serious heart problems or rhythm disturbances.
For international patients who need specialist assessment, Acibadem International’s multidisciplinary teams and JCI-accredited hospitals diagnose and treat complex heart conditions, including obstructive hypertrophic cardiomyopathy. A cardiologist can help confirm whether symptoms are due to this condition, whether Camzyos is appropriate, or whether another treatment path is more suitable.
Frequently asked questions
What is Camzyos used for exactly?
Camzyos is used to treat adults with symptomatic obstructive hypertrophic cardiomyopathy. Its purpose is to help reduce obstruction to blood flow from the heart and improve symptoms such as shortness of breath, chest discomfort, and limited exercise tolerance.
Is Camzyos used for all types of hypertrophic cardiomyopathy?
No. Camzyos is not used for every type of hypertrophic cardiomyopathy. Doctors prescribe it for selected adults with the obstructive form of the condition after confirming the diagnosis and checking heart function carefully.
How does Camzyos differ from standard heart medicines?
Camzyos works by targeting cardiac myosin, a protein involved in heart muscle contraction. This makes it different from many common heart medicines, which may mainly slow the heart rate, lower blood pressure, or reduce fluid buildup.
Why do patients taking Camzyos need regular echocardiograms?
Regular echocardiograms help doctors monitor how strongly the heart is pumping and whether the obstruction is improving. This is important because the medicine can reduce contractility too much in some situations, so treatment needs close supervision.
Can Camzyos cure hypertrophic cardiomyopathy?
Camzyos does not cure hypertrophic cardiomyopathy. It is a treatment that may help control symptoms and improve function in people with the obstructive form of the disease. Long-term care still usually includes specialist follow-up and periodic reassessment.
What symptoms should be checked before asking about Camzyos?
Symptoms that deserve evaluation include shortness of breath with activity, chest pain or pressure, dizziness, fainting, palpitations, and reduced exercise capacity. These symptoms can have several causes, so a doctor must determine whether obstructive hypertrophic cardiomyopathy is actually present.
References
- U.S. Food and Drug Administration
- American Heart Association
- American College of Cardiology
- European Society of Cardiology
- National Heart, Lung, and Blood Institute
This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.
Explore treatments in Turkey — costs, top hospitals & a free quote
JCI-accredited · board-certified surgeons · reply within 24h
Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.









